1. Acton, PD & Friston, KJ (1998). Statistical parametric mapping in functional neuroimaging: beyond PET and fMRI activation studies. Eur J Nucl Med, 25: 663–667.
2. Apostolopoulos, V, Xing, PX, Trapani, JA & McKenzie, IF (1993). Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein. Br J Cancer, 67: 713–720.
3. Avril, N, Dose, J, Janicke, F, Ziegler, S, Romer, W, Weber, W, Herz, M, Nauman, W, Graeff, H & Schwaiger, M (1996). Assessment of axillary lymph node involvement in breast cancer. Patients with positron emission tomography using radiolabeled 2 (fluorine 18)-fluoro-2 deoxy-D-glucose. J Natl Cancer Inst, 88: 1204–1209.
4. Biassoni, L, Granowska, M, Carroll, MJ, Mather, SJ, Howell, R, Ellison, D, MacNeil, FA, Wells, CA, Carpenter, R & Britton, KE (1998). Tc-99m labelled SM3 in the pre-operative evaluation of axillary lymph nodes and primary breast cancer with change detection statistical processing as an aid to tumour detection. Br J Cancer, 77: 131–138.
5. Bombardieri, E, Crippa, F, Maffioli, L, Draisma, A, Chiti, A, Agresti, R & Greco, M (1996). Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: can PET with 18F-FDG be considered as the best methods? Int J Oncol, 8: 693–699.